BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20852989)

  • 1. GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats.
    Ku HC; Chen WP; Su MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):463-74. PubMed ID: 20852989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion.
    Ku HC; Chen WP; Su MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):197-207. PubMed ID: 21748358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPP4 deficiency preserved cardiac function in abdominal aortic banding rats.
    Ku HC; Su MJ
    PLoS One; 2014; 9(1):e85634. PubMed ID: 24416433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes.
    Ku HC; Chen WP; Su MJ
    PLoS One; 2013; 8(1):e54518. PubMed ID: 23359639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
    Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
    Zhang Y; Liu Y; Xu J; Sun Q; Yu F; Cheng J; Peng B; Liu W; Xiao Z; Yin J; Han S; He X
    Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium.
    Wallner M; Kolesnik E; Ablasser K; Khafaga M; Wakula P; Ljubojevic S; Thon-Gutschi EM; Sourij H; Kapl M; Edmunds NJ; Kuzmiski JB; Griffith DA; Knez I; Pieske B; von Lewinski D
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):365-75. PubMed ID: 26432951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliptin and GLP-1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide-induced endotoxemia.
    Steven S; Hausding M; Kröller-Schön S; Mader M; Mikhed Y; Stamm P; Zinßius E; Pfeffer A; Welschof P; Agdauletova S; Sudowe S; Li H; Oelze M; Schulz E; Klein T; Münzel T; Daiber A
    Basic Res Cardiol; 2015 Mar; 110(2):6. PubMed ID: 25600227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
    Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
    Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
    Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG
    Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
    Ihara M; Asanuma H; Yamazaki S; Kato H; Asano Y; Shinozaki Y; Mori H; Minamino T; Asakura M; Sugimachi M; Mochizuki N; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1287-97. PubMed ID: 25747753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.
    Ben-Shlomo S; Zvibel I; Shnell M; Shlomai A; Chepurko E; Halpern Z; Barzilai N; Oren R; Fishman S
    J Hepatol; 2011 Jun; 54(6):1214-23. PubMed ID: 21145820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase 4-deficient rats have improved bile secretory function in high fat diet-induced steatosis.
    Ben-Shlomo S; Zvibel I; Rabinowich L; Goldiner I; Shlomai A; Santo EM; Halpern Z; Oren R; Fishman S
    Dig Dis Sci; 2013 Jan; 58(1):172-8. PubMed ID: 22918684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
    Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
    Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of renovascular damage in Zucker diabetic fatty rat by NWT-03, an egg protein hydrolysate with ACE- and DPP4-inhibitory Activity.
    Wang Y; Landheer S; van Gilst WH; van Amerongen A; Hammes HP; Henning RH; Deelman LE; Buikema H
    PLoS One; 2012; 7(10):e46781. PubMed ID: 23071636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thaliporphine ameliorates cardiac depression in endotoxemic rats through attenuating TLR4 signaling in the downstream of TAK-1 phosphorylation and NF-κB signaling.
    Chen WP; Tzeng HJ; Ku HC; Ho YJ; Lee SS; Su MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):441-53. PubMed ID: 20848273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in glucose-induced plasma active glucagon-like peptide-1 levels by co-administration of sodium-glucose cotransporter inhibitors with dipeptidyl peptidase-4 inhibitors in rodents.
    Oguma T; Kuriyama C; Nakayama K; Matsushita Y; Hikida K; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Minami M; Shiotani M
    J Pharmacol Sci; 2016 Dec; 132(4):255-261. PubMed ID: 27889414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase-4 disturbs adipocyte differentiation via the negative regulation of the glucagon-like peptide-1/adiponectin-cathepsin K axis in mice under chronic stress conditions.
    Zhang M; Yue X; Xu S; Piao J; Zhao L; Shu S; Kuzuya M; Li P; Hong L; Kim W; Liu B; Cheng XW
    FASEB J; 2024 May; 38(10):e23684. PubMed ID: 38795334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.
    Du J; Zhang L; Wang Z; Yano N; Zhao YT; Wei L; Dubielecka-Szczerba P; Liu PY; Zhuang S; Qin G; Zhao TC
    Am J Physiol Cell Physiol; 2016 Feb; 310(4):C270-83. PubMed ID: 26739490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.